...
首页> 外文期刊>Evidence-based complementary and alternative medicine: eCAM >Antidiabetic Effect of Oral Borapetol B Compound, Isolated from the Plant Tinospora crispa, by Stimulating Insulin Release
【24h】

Antidiabetic Effect of Oral Borapetol B Compound, Isolated from the Plant Tinospora crispa, by Stimulating Insulin Release

机译:通过刺激胰岛素的释放,从植物脆皮草中分离出的口服硼砂甲酚B化合物具有抗糖尿病作用

获取原文
获取原文并翻译 | 示例

摘要

Aims. To evaluate the antidiabetic properties of borapetol B known as compound 1 (Cl) isolated from Tinospora crispa in normoglycemic control Wistar (W) and spontaneously type 2 diabetic Goto-Kakizaki (GK) rats. Methods. The effect of Cl on blood glucose and plasma insulin was assessed by an oral glucose tolerance test. The effect of Cl on insulin secretion was assessed by batch incubation and perifusion experiments using isolated pancreatic islets. Results. An acute oral administration of Cl improved blood glucose levels in treated versus placebo groups with areas under glucose curves 0-120 min being 72 ± 17 versus 344 ±10 mmol/L (P < 0.001) and 492 ± 63 versus 862 ± 55 mmol/L (P < 0.01) in W and GK rats, respectively. Plasma insulin levels were increased by 2-fold in treated W and GK rats versus placebo group at 30 min (P < 0.05). Cl dose-dependently increased insulin secretion from W and GK isolated islets at 3.3 mM and 16.7 mM glucose. The perifusions of isolated islets indicated that Cl did not cause leakage of insulin by damaging islet beta cells (P < 0.001). Conclusion. This study provides evidence that borapetol B (Cl) has antidiabetic properties mainly due to its stimulation of insulin release.
机译:目的为了评估在正常血糖控制Wistar(W)和自发性2型糖尿病后藤崎崎(GK)大鼠中从丁香孢(Tinospora crispa)分离出的被称为化合物1(Cl)的borapetol B的抗糖尿病特性。方法。通过口服葡萄糖耐量试验评估C1对血糖和血浆胰岛素的作用。通过使用分离的胰岛的分批温育和灌注试验评估C1对胰岛素分泌的作用。结果。急性口服Cl改善了治疗组与安慰剂组的血糖水平,葡萄糖曲线在0-120分钟以下的面积分别为72±17对344±10 mmol / L(P <0.001)和492±63对862±55 mmol / L在W和GK大鼠中分别为L(P <0.01)。与安慰剂组相比,治疗的W和GK大鼠血浆胰岛素水平在30分钟时增加了2倍(P <0.05)。 Cl在3.3 mM和16.7 mM的葡萄糖下剂量依赖性地增加了从W和GK分离的胰岛的胰岛素分泌。离体胰岛的灌注表明,C1不会通过破坏胰岛β细胞而引起胰岛素渗漏(P <0.001)。结论。这项研究提供的证据表明,波普拉托B(Cl)具有抗糖尿病特性,这主要是由于其刺激了胰岛素的释放。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号